公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2013 | The germline BIM deletion polymorphism is not associated with the treatment efficacy of sorafenib in patients with advanced hepatocellular carcinoma | YU-YUN SHAO ; Chang Y.-L.; Huang C.-Y.; CHIH-HUNG HSU ; ANN-LII CHENG | Oncology (Switzerland) | 5 | 5 | |
2006 | Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity | YEN-SHEN LU ; HUANG-CHUN LIEN ; Yeh P.-Y.; SUNG-HSIN KUO ; Chang W.-C.; Kuo M.-L.; ANN-LII CHENG | Lung Cancer | 35 | 34 | |
2006 | Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-κB activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa | YEN-SHEN LU ; Yeh P.-Y.; Chuang S.-E.; Gao M.; Kuo M.-L.; ANN-LII CHENG | Journal of Endocrinology | 23 | 21 | |
2015 | Growth arrest dna damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma | DA-LIANG OU ; Shyue S.-K.; LIANG-IN LIN ; Feng Z.-R.; Liou J.-Y.; Fan H.-H.; Lee B.-S.; CHIUN HSU ; ANN-LII CHENG | Oncotarget | 12 | 9 | |
1995 | Growth of E.coli at low temperature dramatically increases the transformation frequency by electroporation | Chuang S.-E.; ANN-LII CHENG ; Chao C.-C. | Nucleic Acids Research | 20 | 19 | |
2017 | Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST study | Hagiwara Y.; Ohashi Y.; Okusaka T.; Ueno H.; Ioka T.; Boku N.; Egawa S.; Hatori T.; Furuse J.; Mizumoto K.; Ohkawa S.; Yamaguchi T.; Yamao K.; Funakoshi A.; ANN-LII CHENG ; Kihara K.; Sato A.; Tanaka M. | ESMO Open | 10 | 40 | |
2021 | Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYnote-240 | Ryoo B.-Y.; Merle P.; Kulkarni A.S.; ANN-LII CHENG ; Bouattour M.; Lim H.Y.; Breder V.; Edeline J.; Chao Y.; Ogasawara S.; Yau T.; Garrido M.; Chan S.L.; Daniele B.; Norquist J.M.; Chen E.; Siegel A.B.; Zhu A.X.; Finn R.S.; Kudo M. | Cancer | 13 | 17 | |
2013 | Helicobacter pylori and mucosa-associated lymphoid tissue: what's new | SUNG-HSIN KUO ; ANN-LII CHENG | Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program | 45 | 43 | |
2015 | Helicobacter pylori CagA translocation is closely associated with the expression of caga-signaling molecules in low-grade gastric mucosa-associated lymphoid tissue lymphoma | SUNG-HSIN KUO ; KUN-HUEI YEH ; Chen L.-T.; CHUNG-WU LIN ; PING-NING HSU ; MING-SHIANG WU ; JYH-MING LIOU ; Tsai H.-J.; Tzeng Y.-S.; ANN-LII CHENG | American Journal of Surgical Pathology | 16 | 16 | |
2012 | Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas | SUNG-HSIN KUO ; KUN-HUEI YEH ; MING-SHIANG WU ; CHUNG-WU LIN ; PING-NING HSU ; HSIU-PO WANG ; Chen L.-T.; ANN-LII CHENG | Blood | 114 | 93 | |
2014 | Helicobacter pylori sensitizes TNF-related apoptosisinducing ligand (TRAIL)-mediated apoptosis in human gastric epithelial cells through regulation of FLIP | Lin W.-C.; Tsai H.-F.; Liao H.-J.; Tang C.-H.; Wu Y.-Y.; Hsu P.-I.; ANN-LII CHENG ; PING-NING HSU | Cell Death and Disease | 21 | 19 | |
2014 | Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: A distinct entity with lower aggressiveness and higher chemosensitivity | SUNG-HSIN KUO ; KUN-HUEI YEH ; Chen L.-T.; CHUNG-WU LIN ; PING-NING HSU ; CHIUN HSU ; MING-SHIANG WU ; Tzeng Y.-S.; Tsai H.-J.; HSIU-PO WANG ; ANN-LII CHENG | Blood Cancer Journal | 34 | 32 | |
1995 | Hemophagocytic syndrome in epstein-Barr virus-associated t-lymphoproliferative disorders: Disease spectrum, pathogenesis, and management | Su I.-J.; Wang C.-H.; ANN-LII CHENG ; Chen R.-L. | Leukemia and Lymphoma | 124 | 101 | |
2023 | Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab | CHIUN HSU ; Ducreux, Michel; Zhu, Andrew X; Qin, Shukui; Ikeda, Masafumi; Kim, Tae-You; Galle, Peter R; Finn, Richard S; Chen, Ethan; Ma, Ning; Hu, Youyou; Li, Lindong; ANN-LII CHENG | Liver cancer | 1 | 0 | |
2013 | Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group | Kim S.J.; CHIUN HSU ; Song Y.-Q.; Tay K.; Hong X.-N.; Cao J.; Kim J.S.; Eom H.S.; Lee J.H.; Zhu J.; Chang K.-M.; Reksodiputro A.H.; Tan D.; Goh Y.T.; Lee J.; Intragumtornchai T.; Chng W.-J.; ANN-LII CHENG ; Lim S.T.; Suh C.; Kwong Y.-L.; Kim W.S. | European Journal of Cancer | 98 | 90 | |
2003 | Hepatitis B virus X protein activates a survival signaling by linking Src to phosphatidylinositol 3-kinase | Shih W.-L.; Kuo M.-L.; Chuang S.-E.; ANN-LII CHENG ; SHIN-LIAN DOONG | Journal of Biological Chemistry | 52 | 49 | |
2000 | Hepatitis b virus x protein inhibits transforming growth factor-β-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway | Shih W.-L.; Kuo M.-L.; Chuang S.-E.; ANN-LII CHENG ; SHIN-LIAN DOONG | Journal of Biological Chemistry | 174 | 163 | |
2017 | Hepatitis C virus core protein potentiates proangiogenic activity of hepatocellular carcinoma cells | YU-YUN SHAO ; MIN-SHU HSIEH ; Wang, Han Yu; Li, Yong Shi; Lin, Hang; Hsu, Hung Wei; Huang, Chung Yi; CHIH-HUNG HSU ; ANN-LII CHENG | Oncotarget | 12 | 9 | |
2002 | HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity | CHIUN HSU ; Huang C.-L.; Hsu H.-C.; PO-HUANG LEE ; Wang S.-J.; ANN-LII CHENG | Cancer | 41 | 33 | |
2018 | The HER2 inhibitor lapatinib potentiates doxorubicininduced cardiotoxicity through iNOS signaling | WAN-TSENG HSU ; Huang C.-Y.; Yen C.Y.T.; ANN-LII CHENG ; Hsieh P.C.H. | Theranostics | 36 | 33 | |